October 2021
CMS Partners in Medicine Lunch and Learn webinar
The Security Risk Analysis - Abyde, Nov. 10

Believe it or not, this year is almost over -- and with time flying that means annual HIPAA and MIPS Security Risk Analysis (SRA) deadlines will be here before we know it, too! This year, don't wait until the last minute. Join Colorado Medical Society's preferred HIPAA compliance partner, Abyde, on Wednesday, Nov. 10 at 12 p.m. MST for a live 30-minute webinar on how to quickly and efficiently knock out the most crucial step in a HIPAA compliance program -- the Security Risk Analysis.
We need your feedback: Is prior authorization getting better?
How has the burden of prior authorizations changed since Jan. 1, 2020?

  • Increased significantly
  • Increased somewhat
  • No change
  • Decreased somewhat
  • Decreased significantly
Do any of the health plans with which you contract offer programs that exempt physicians from prior authorization requirements?

  • Yes
  • No
  • Unsure
CPT update for pediatric COVID-19 vaccine candidate

The American Medical Association (AMA) announced that the Current Procedural Terminology (CPT®) code set has been updated by the CPT Editorial Panel to include vaccine and administration codes for pediatric doses of the COVID-19 vaccine developed by Pfizer. Quick reference:

Vaccine Product Code:

91307  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use

Vaccine Administration Codes:

0071A  Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose

0072A  Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose
COVID-19 vaccines: New booster dose of Pfizer vaccine

On Sept. 22, 2021, the FDA amended the emergency use authorization for the Pfizer-BioNTech (PDF) COVID-19 vaccine to allow a single booster dose for certain populations. A new code describing the service to administer a booster dose of Pfizer BioNTech COVID-19 vaccine (0004A) has been established. CMS added the fee for this code to the Centers for Medicare and Medicaid Services (federal CMS) COVID-19 vaccines and monoclonal antibodies webpage.
Notice to employers: Coloradans are still entitled to COVID-related sick leave while federal public health emergency remains in effect 

Under the Healthy Families and Workplaces Act (HFWA), Coloradans can take up to 80 hours of paid leave in 2021 for any COVID-related needs. This includes not only having COVID-19, but also going to get a COVID-19 test or vaccine, recovering from any vaccine side effects, following a mandatory quarantine, or caring for a family member with any of those needs. This policy continues until four weeks after all applicable public health emergencies end or are suspended. The latest federal declaration extends through Oct. 18, 2021. For more information on paid sick leave, please see the CDLE Division of Labor Standards and Statistics’ fact sheets, INFOs #6B and 6C.
Thanks to our Partners in Medicine, who support Colorado physicians and practices!
What products or services would be most valuable to your practice?
As the Colorado Medical Society builds a robust program of valuable and vetted partners through the Partners in Medicine program, we need your input! What types of products, services or resources would be most helpful to your practice and others like yours? Share your ideas; email dianna_fetter@cms.org
Latest bulletins